2024. Progressive and Sustained Disease Control in Patients with Atopic Dermatitis (AD) Aged 12–17 Years Treated with Tralokinumab for 52 Weeks. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s377. DOI:https://doi.org/10.25251/skin.8.supp.377.